Quality improvement practitioners have traditionally used 3 types of measures or metrics to help track what type of change a quality improvement project produces. The 3 traditional measure types are: process measure, outcome measure, and balancing measure. An equity measure is a new type of measure that is designed to identify and address existing inequities and barriers to attaining health equity for all people, and should be utilized going forward for all quality improvement projects including implementation of this guideline.
Quality Improvement Metrics Defined
Quality Improvement Metrics
The following are examples of quality metrics that could be used by individual providers, health care systems, or multi-center quality improvement collaboratives to monitor adherence to the American Academy of Pediatrics Guideline for Faltering Weight.
Equity Note: Each of the measures should be evaluated with an equity lens by stratifying the data by race, ethnicity, preferred language, sex, gender, and insurance type. Additional stratifications can be done as indicated based on identified inequities.
|
Measure Name |
Type of Measure | Definition | Calculation |
|
Example: Bili Discharge |
Example: process, balancing, outcome; equity |
Example: Routine bilirubin testing for newborns discharged before 24 hours |
Example Numerator: At least one total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) measure before discharge Example Denominator: Newborns discharged at or before 24h after birth |
|
Faltering Weight Evaluation (KAS 2) |
Process |
Patients evaluated for faltering weight should have an initial evaluation that includes: detailed medical history, family history, social history, feeding history, growth history, growth assessment and detailed physical exam |
Numerator: Number of patients with all aspects of history and physical exam Denominator: Total number of patients evaluated for faltering weight |
|
Equity in Faltering Weight Evaluation (KAS 1) |
Process |
All patients undergoing evaluation for faltering weight should be evaluated with the same criteria regardless of race or socioeconomic status |
Numerators: Denominator: Total number of (white, Black, Hispanic or Asian/Pacific Islander, Native American etc.) patients evaluated for faltering weight |
|
Faltering Weight Diagnostic Testing (KAS 2) |
Process |
Patients undergoing initial evaluation for faltering weight did not undergo diagnostic testing |
Numerator: Number of patients evaluated for faltering weight that had NO diagnostic tests performed Denominator: Total number of patients evaluated for faltering weight |
|
Faltering Weight Treatment (KAS 4) |
Process |
Increased calories should be the first treatment recommendation for all patients with faltering weight |
Numerator: Number of patients who were given the recommendation to increase calories Denominator: Total number of patients diagnosed with faltering weight |
|
Faltering Weight Patient Growth (KAS 1 – 6) |
Outcome |
Patients with faltering weight who have been appropriately diagnosed and treated will no longer meet the criteria for faltering weight 6 months after initial diagnosis |
Numerator: Number of patients diagnosed with faltering weight who no longer met the criteria after 6 months of treatment Denominator: Total number of patients diagnosed with faltering weight |
|
Feeding Therapy (KAS 6) |
Outcome |
Patients with documented feeding issues should be referred for feeding therapy |
Numerator: Number of patients with feeding issues referred for feeding therapy Denominator: Total number of patients with faltering weight who were identified as having feeding issues |
|
Faltering Weight Diagnosis Delayed (KAS 1 - 6) |
Balancing |
Patients with faltering weight who had a delay in diagnosis |
Numerator: Number of patients who were not diagnosed during the initial evaluation but were subsequently diagnosed with faltering weight Denominator: Total number of patients diagnosed with faltering weight |
|
Patients Needing Diagnostic Testing (KAS 2) |
Balancing |
Patients with faltering weight who did not meet the criteria for lab evaluation at the initial evaluation (based on algorithm), but who had lab tests performed on follow-up evaluation. |
Numerator: Number of patients who had lab testing performed on any follow-up evaluation. Denominator: Total number of patients evaluated for faltering weight |
Acknowledgement
Nicole Anania, DO, MS, FAAP, served as the Implementation Scientist on the recently published American Academy of Pediatrics Faltering Weight Clinical Practice Guideline. Most recently, she was a Professor of Pediatrics at the University of Kentucky and Medical Director for Inpatient Pediatrics at Med Center Health in Bowling Green, KY. Prior to that, she served as a Master Clinician and Director of Quality Improvement for the Outreach Division of Ann & Robert H. Lurie Children's Hospital of Chicago and has extensive experience working with children with medical complexity and faltering weight.
Last Updated
03/11/2026
Source
American Academy of Pediatrics